Prima BioMed Enters Into Sale, Licensing Agreement With Sydys to Advance CVac Program

By: via Benzinga
Prima BioMed Ltd (NASDAQ: PBMD) and U.S.-based Sydys Corporation, Inc. (OTC: SYYC) ("Sydys"), today announced an agreement through ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.